# Auson

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/auson

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.ausonpharma.com
- Total disclosed funding: $30M
- Latest round: Series B (Aug 5, 2022)
- Investors on record: 7

## About

Established in 2019 and based in Shanghai, China, Auson operates as a biopharmaceutical developer focuses on the development of the biopharmaceutical for antiviral and vascular disease. The company is headquartered in Shanghai and has a branch office in New Jersey. Dr. Enxian Lu, the founder and CEO of the company, has a Master of Pharmacy from Fudan University, a Master of Biopharmacy from the University of Illinois, and a Doctor of Pharmacy from the University of Minnesota, with over 20 years of experience in MNC pharmaceutical companies and start-ups.

The company's main business is the research, development and production of formulation-improving new drugs. The company's self-developed products include patented product ASN001 for the treatment of infantile hemangioma and patented product ASN008 for the treatment of hepatitis B. The products are used in the field of pediatrics, vascular diseases and antiviral.

## Funding rounds

- Series B, Aug 5, 2022, $15M — CMS Asset Management, Kaitai Capital, Shanghai Zhangjiang Science & Technology Venture Capital, DYEE Capital, Chobe Capital
- Series A, Jun 15, 2021, $10M — Asia View Capital, Shanghai Zhangjiang Science & Technology Venture Capital, Topping Capital
- Seed, Nov 7, 2019, $5M — Kaitai Capital

## Investors

- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Seed, Series B
- Asia View Capital (https://capitalatlas.ai/funds/asia-view-capital) — Series A
- Shanghai Zhangjiang Science & Technology Venture Capital — Series A, Series B
- Topping Capital (https://capitalatlas.ai/funds/topping-capital) — Series A
- CMS Asset Management (https://capitalatlas.ai/funds/cms-asset-management) — Series B
- DYEE Capital (https://capitalatlas.ai/funds/dyee-capital) — Series B
- Chobe Capital (https://capitalatlas.ai/funds/chobe-capital) — Series B